Sg Americas Securities, LLC Sangamo Therapeutics, Inc Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.42 - $1.38 $51,223 - $168,304	-121,960 Reduced 67.55%	58,584 $39,000
Q4 2023 Jan 12, 2024	BUY	$0.3 - $0.63 $27,600 - $57,961	92,002 Added 103.91%	180,544 $98,000
Q3 2023 Oct 13, 2023	BUY	$0.58 - $1.47 $36,894 - $93,509	63,612 Added 255.16%	88,542 $53,000
Q2 2023 Jul 10, 2023	SELL	$1.11 - $1.74 $54,640 - $85,653	-49,226 Reduced 66.38%	24,930 $32,000
Q1 2023 Apr 28, 2023	BUY	$1.66 - $3.67 $36,563 - $80,835	22,026 Added 42.25%	74,156 $131,000
Q4 2022 Feb 02, 2023	SELL	$2.77 - $5.07 $61,336 - $112,265	-22,143 Reduced 29.81%	52,130 $164,000
Q3 2022 Oct 31, 2022	SELL	$4.27 - $6.39 $211,083 - $315,883	-49,434 Reduced 39.96%	74,273 $364,000
Q2 2022 Jul 29, 2022	BUY	$3.28 - $6.21 $405,758 - $768,220	123,707 New	123,707 $512,000
Q1 2022 Apr 29, 2022	SELL	$5.23 - $7.82 $200,220 - $299,373	-38,283 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$7.29 - $10.97 $4.59 Million - $6.91 Million	-629,498 Reduced 94.27%	38,283 $287,000
Q3 2021 Nov 01, 2021	BUY	$9.01 - $12.01 $435,687 - $580,755	48,356 Added 7.81%	667,781 $6.02 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $5.35 Million - $6.65 Million	525,952 Added 562.68%	619,425 $7.42 Million
Q1 2021 May 13, 2021	BUY	$10.88 - $17.05 $680,228 - $1.07 Million	62,521 Added 201.99%	93,473 $1.17 Million
Q4 2020 Feb 04, 2021	SELL	$9.23 - $18.18 $515,717 - $1.02 Million	-55,874 Reduced 64.35%	30,952 $483,000
Q3 2020 Nov 09, 2020	BUY	$9.38 - $12.48 $653,213 - $869,094	69,639 Added 405.18%	86,826 $821,000
Q2 2020 Jul 20, 2020	SELL	$6.21 - $11.83 $935,430 - $1.78 Million	-150,633 Reduced 89.76%	17,187 $154,000
Q1 2020 Apr 30, 2020	BUY	$5.05 - $8.85 $847,491 - $1.49 Million	167,820 New	167,820 $1.07 Million
Q4 2019 Jan 28, 2020	SELL	$8.03 - $11.7 $137,618 - $200,514	-17,138 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$9.05 - $12.22 $37,105 - $50,102	-4,100 Reduced 19.31%	17,138 $155,000
Q2 2019 Jul 29, 2019	BUY	$8.75 - $13.03 $185,832 - $276,731	21,238 New	21,238 $229,000
Q3 2018 Nov 06, 2018	SELL	$13.05 - $19.05 $123,766 - $180,670	-9,484 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$13.9 - $19.8 $639 - $910	-46 Reduced 0.48%	9,484 $135,000
Q1 2018 May 03, 2018	SELL	$16.7 - $26.35 $583,063 - $919,983	-34,914 Reduced 78.56%	9,530 $181,000
Q4 2017 Jan 24, 2018	SELL	$11.6 - $17.35 $311,344 - $465,674	-26,840 Reduced 37.65%	44,444 $729,000
Q3 2017 Nov 07, 2017	BUY	$8.4 - $15.0 $598,785 - $1.07 Million	71,284	71,284 $1.07 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account